Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000487 |
Allethrin |
Allethrin inhibits the reaction [CACNA1C protein results in increased transport of Calcium] | decreases reaction|increases transport | 14634047
|
D000638 |
Amiodarone |
Amiodarone results in decreased expression of CACNA1C mRNA | decreases expression | 15520326
|
D000661 |
Amphetamine |
Amphetamine results in increased expression of CACNA1C mRNA | increases expression | 15329393
|
D000661 |
Amphetamine |
Amphetamine results in increased expression of CACNA1C protein | increases expression | 15329393
|
D001262 |
Atenolol |
CACNA1C gene polymorphism results in increased susceptibility to Atenolol | increases response to substance | 20031608
|
D001464 |
Barium |
CACNA1C protein affects the transport of Barium | affects transport | 11724757
|
D001464 |
Barium |
Zeneca ZD 6169 inhibits the reaction [CACNA1C protein affects the transport of Barium] | affects transport|decreases reaction | 11724757
|
D001464 |
Barium |
CACNA1C protein results in increased transport of Barium | increases transport | 17569661
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of CACNA1C mRNA | increases expression | 17989879
|
D002118 |
Calcium |
CACNA1C protein results in increased transport of Calcium | increases transport | 15299022
|
D002118 |
Calcium |
Allethrin inhibits the reaction [CACNA1C protein results in increased transport of Calcium] | decreases reaction|increases transport | 14634047
|
D002118 |
Calcium |
CACNA1C protein results in increased transport of Calcium | increases transport | 14634047
|
D007545 |
Isoproterenol |
Isoproterenol results in increased expression of CACNA1C mRNA | increases expression | 17526999
|
D009538 |
Nicotine |
Nicotine results in increased expression of CACNA1C protein | increases expression | 11756415
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of CACNA1C mRNA | decreases expression | 19465110
|
D014415 |
Tunicamycin |
Tunicamycin results in increased expression of CACNA1C mRNA | increases expression | 17127020
|
D014700 |
Verapamil |
CACNA1C gene polymorphism results in increased susceptibility to Verapamil | increases response to substance | 20031608
|
C095007 |
Zeneca ZD 6169 |
Zeneca ZD 6169 inhibits the reaction [CACNA1C protein affects the transport of Barium] | affects transport|decreases reaction | 11724757
|
D015032 |
Zinc |
Zinc results in increased expression of CACNA1C mRNA | increases expression | 17074742 15159208
|
D019287 |
Zinc Sulfate |
Zinc Sulfate results in increased expression of CACNA1C mRNA | increases expression | 17074742
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.90 | 15322242 11752688 14514962 |
MESH:D000138 |
Acidosis |
|
Zinc Sulfate |
4.96 | 7265320 |
MESH:D000169 |
Acrodermatitis |
|
Zinc |
5.45 | 17202136 16889938 17190629 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.43 | 16835633 |
MESH:D000544 |
Alzheimer Disease |
|
Nicotine |
4.78 | 16627626 |
MESH:D000544 |
Alzheimer Disease |
|
Zinc |
4.78 | 16325427 16410023 16580781 17119284 |
MESH:D019969 |
Amphetamine-Related Disorders |
|
Amphetamine |
6.11 | 16916582 18475255 16459022 15010207 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.97 | 11748828 |
MESH:D000755 |
Anemia, Sickle Cell |
|
Zinc |
4.94 | 16916123 |
MESH:D000855 |
Anorexia |
|
Amphetamine |
5.04 | 12183048 16084549 16101753 12005258 |
MESH:D000860 |
Anoxia |
|
Zinc Sulfate |
5.07 | 7265320 |
MESH:D001145 |
Arrhythmias, Cardiac |
marker/mechanism |
|
| 15454078 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Amiodarone |
3.83 | 18218290 18057881 20041841 |
MESH:D001249 |
Asthma |
|
Zinc |
2.96 | 17085522 |
MESH:D001281 |
Atrial Fibrillation |
|
Amiodarone |
3.92 | 19698954 18651412 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 15454078 |
MESH:D001714 |
Bipolar Disorder |
marker/mechanism |
|
| 18711365 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Amiodarone |
9.14 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.14 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.85 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.78 | 15746008 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.89 | 11985600 |
MESH:D001919 |
Bradycardia |
|
Isoproterenol |
5.23 | 6740701 |
MESH:D001930 |
Brain Injuries |
|
Zinc |
4.73 | 17109824 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
2.05 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.05 | 20435547 |
MESH:D053840 |
Brugada Syndrome |
marker/mechanism |
|
| |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.82 | 16835633 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
5.04 | 17123778 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Zinc |
2.91 | 16543248 |
MESH:D006332 |
Cardiomegaly |
|
Atenolol |
11.84 | 15969258 |
MESH:D006332 |
Cardiomegaly |
|
Isoproterenol |
11.84 | 7544033 11179087 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
11.84 | 18850075 18670907 16120746 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Amiodarone |
2.90 | 19225199 15710769 |
MESH:D002318 |
Cardiovascular Diseases |
|
Zinc |
3.68 | 16936243 |
MESH:D002341 |
Carotid Artery Thrombosis |
|
Amiodarone |
5.13 | 18974383 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.19 | 16835633 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.11 | 15668235 12621046 16354765 15340226 8697196 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.08 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.68 | 10048152 20055451 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Zinc |
2.68 | 19302082 |
MESH:D003920 |
Diabetes Mellitus |
|
Zinc |
4.23 | 16479319 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.67 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Amiodarone |
3.88 | 18218290 15265979 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.88 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.78 | 11462148 |
MESH:D020821 |
Dystonic Disorders |
|
Nicotine |
5.98 | 17881519 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.41 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.96 | 18230668 15322242 16714409 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.05 | 10568697 9294722 |
MESH:D004938 |
Esophageal Neoplasms |
|
Zinc |
2.86 | 16543248 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.03 | 11564622 |
MESH:D005221 |
Fatigue |
|
Amphetamine |
5.65 | 19890266 |
MESH:D005234 |
Fatty Liver |
|
Amiodarone |
3.55 | 14986274 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.50 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
2.99 | 20067830 |
MESH:D005756 |
Gastritis |
|
Zinc |
4.86 | 17241300 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.66 | 10696789 |
MESH:D006130 |
Growth Disorders |
|
Zinc |
3.98 | 17217573 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.34 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
Atenolol |
12.41 | 20082655 |
MESH:D006333 |
Heart Failure |
|
Isoproterenol |
12.41 | 18097624 |
MESH:D006333 |
Heart Failure |
|
Zinc |
12.41 | 17162251 |
MESH:D006335 |
Heart Injuries |
|
Zinc |
5.83 | 17074742 |
MESH:D016481 |
Helicobacter Infections |
|
Zinc |
4.56 | 17241300 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.36 | 11000095 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Zinc |
11.46 | 17276780 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Zinc Sulfate |
11.46 | 17063115 |
MESH:D006529 |
Hepatomegaly |
|
Amiodarone |
8.68 | 15265979 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.68 | 16120746 12621046 15340226 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.11 | 16354765 15340226 18606429 16959395 8697196 |
MESH:D006937 |
Hypercholesterolemia |
|
Amiodarone |
3.90 | 8137927 9751232 |
MESH:D006948 |
Hyperkinesis |
|
Amphetamine |
5.48 | 1977408 14960337 |
MESH:D006973 |
Hypertension |
|
Atenolol |
9.11 | 15453913 12022239 15614026 12717102 14597852 15237695 15969258 15188945 14700505 19249413 11910301 11593098 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
9.11 | 18670907 18850075 |
MESH:D006973 |
Hypertension |
|
Verapamil |
9.11 | 17700361 |
MESH:D006984 |
Hypertrophy |
|
Isoproterenol |
5.22 | 12791704 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
Atenolol |
5.73 | 15237695 |
MESH:D007003 |
Hypoglycemia |
marker/mechanism |
|
| 15454078 |
MESH:D007022 |
Hypotension |
|
Isoproterenol |
9.86 | 6740701 |
MESH:D007022 |
Hypotension |
|
Zinc Sulfate |
9.86 | 7265320 |
MESH:D007037 |
Hypothyroidism |
|
Amiodarone |
4.56 | 18020914 17991464 |
MESH:D007153 |
Immunologic Deficiency Syndromes |
marker/mechanism |
|
| 15454078 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.87 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
3.31 | 16393666 |
MESH:D007511 |
Ischemia |
|
Zinc |
4.67 | 16584753 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.36 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Zinc |
3.33 | 16960431 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Zinc |
4.45 | 16518626 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Calcium |
5.11 | 16316344 |
MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Zinc Sulfate |
4.28 | 15237267 |
MESH:D017880 |
Limb Deformities, Congenital |
marker/mechanism |
|
| 15454078 |
MESH:D008064 |
Lipidoses |
|
Amiodarone |
3.53 | 15342952 17567588 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
1.24 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
1.73 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.12 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
Amiodarone |
3.60 | 15350150 17391786 11989578 |
MESH:D008171 |
Lung Diseases |
|
Amiodarone |
3.39 | 12587719 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Amiodarone |
4.54 | 18516814 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
1.23 | 11884234 19555203 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Zinc |
3.31 | 12773700 |
MESH:D008382 |
Marfan Syndrome |
|
Atenolol |
6.29 | 19430350 |
MESH:D009181 |
Mycoses |
|
Amiodarone |
4.96 | 17974566 12754197 |
MESH:D009203 |
Myocardial Infarction |
|
Isoproterenol |
3.85 | 16538859 16697266 17052832 15740881 19595682 16584858 19172585 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.04 | 12213967 |
MESH:D009369 |
Neoplasms |
|
Nicotine |
3.55 | 16365874 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Nicotine |
5.04 | 16365874 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
9.71 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.71 | 14600291 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Amphetamine |
4.67 | 15183010 |
MESH:D010024 |
Osteoporosis |
|
Calcium |
3.80 | 17882678 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
5.04 | 11985600 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.31 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.59 | 18163543 |
MESH:D011225 |
Pre-Eclampsia |
|
Zinc |
4.19 | 17114810 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
9.68 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.68 | 11118676 11399792 11896295 11222880 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
4.24 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
3.53 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Zinc |
3.53 | 16606632 12429649 16700911 16517595 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.84 | 10548101 |
MESH:D011654 |
Pulmonary Edema |
|
Isoproterenol |
5.31 | 10903255 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Amiodarone |
2.86 | 12832656 12490602 11597910 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.87 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
Zinc |
4.15 | 16584753 |
MESH:D012640 |
Seizures |
|
Nicotine |
3.81 | 17873105 |
OMIM:609620 |
SHORT QT SYNDROME 1 |
|
Amiodarone |
5.13 | 18724381 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.05 | 16192470 |
MESH:D019956 |
Stereotypic Movement Disorder |
|
Amphetamine |
6.49 | 1977408 |
MESH:D013276 |
Stomach Ulcer |
|
Amiodarone |
3.34 | 18087811 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
4.03 | 16045194 16684133 |
MESH:D013610 |
Tachycardia |
|
Amiodarone |
4.32 | 11238279 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Amiodarone |
4.22 | 19225199 |
MESH:D013959 |
Thyroid Diseases |
|
Amiodarone |
12.26 | 19731979 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
12.26 | 12697716 |
MESH:D018382 |
Thyroid Hormone Resistance Syndrome |
|
Atenolol |
6.43 | 9349583 |
MESH:D013971 |
Thyrotoxicosis |
|
Amiodarone |
4.90 | 19584973 18020914 |
MESH:C536962 |
Timothy syndrome |
marker/mechanism |
|
| 15454078 |
OMIM:188890 |
TOBACCO ADDICTION, SUSCEPTIBILITY TO |
|
Nicotine |
4.75 | 11259349 16785264 16720336 |
MESH:D014029 |
Tobacco Use Disorder |
|
Nicotine |
5.49 | 15735609 18305452 17979512 18041664 |
MESH:D014062 |
Tongue Neoplasms |
|
Zinc |
4.42 | 16543248 |
MESH:D016171 |
Torsades de Pointes |
|
Amiodarone |
4.24 | 11989578 17467628 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
5.07 | 14652134 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.66 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Isoproterenol |
5.16 | 18097624 |
MESH:D020257 |
Ventricular Remodeling |
|
Isoproterenol |
5.74 | 18097624 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.31 | 15886252 |